Glenmark Pharmaceuticals Ltd Price Performance
- Day's Low
- ₹1,390.20
- Day's High
- ₹1,412.25
₹ 1,408.85
- 52-w low
- ₹883
- 52-w high
- ₹1,830.95
1,408.85
- Day's open
₹1,400.10 - Previous close
₹1,400.20 - VWAP
₹1,401.09 - Lower price band
₹1,260.20 - Upper price band
₹1,540.20
Today's Market Action
The last traded share price of Glenmark Pharmaceuticals Ltd was 1,408.85 up by 0.62% on the NSE. Its last traded stock price on BSE was 1,410.15 up by 0.69%. The total volume of shares on NSE and BSE combined was 63,382 shares. Its total combined turnover was Rs 8.88 crores.
Glenmark Pharmaceuticals Ltd Medium and Long Term Market Action
Glenmark Pharmaceuticals Ltd hit a 52-week high of 1,830.95 on 15-10-2024 and a 52-week low of 883 on 14-03-2024.
The stock price of Glenmark Pharmaceuticals Ltd is down by -7% over the last one month. It is up by 47.37% over the last one year. Don't forget to check the full stock price history in the table below.
Glenmark Pharmaceuticals Ltd Fundamentals
-
Market Cap (Cr): 43279
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Glenmark Pharmaceuticals Ltd Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About Glenmark Pharmaceuticals Ltd
Data not available.
Glenmark Pharmaceuticals Ltd FAQ's
What is Share Price of Glenmark Pharmaceuticals Ltd?
What is the Market Cap of Glenmark Pharmaceuticals Ltd?
What is PE Ratio of Glenmark Pharmaceuticals Ltd?
What is PB Ratio of Glenmark Pharmaceuticals Ltd?
What is the CAGR of Glenmark Pharmaceuticals Ltd?
How to Buy Glenmark Pharmaceuticals Ltd Share?
Financials
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
News
Review
Pros
- No Data Available
Cons
Low Sustainable RoE
Low Return on Capital Employed
Poor Cash Flow Conversion
Low Interest Coverage
Highly Cyclical Industry
Poor Working Capital Cycle
Valuation Analysis
Margin of safety
(12/03/2025)
(12/03/2025)


104
84.21% People are bullish about Glenmark Pharmaceuticals Ltd
15.79 % People are bearish about Glenmark Pharmaceuticals Ltd